148 related articles for article (PubMed ID: 7198859)
1. Fibrinolytic activity of cerebral tissue after experimental subarachnoid haemorrhage: inhibitory effect of tranexamic acid (AMCA).
Fodstad H; Kok P; Algers G
Acta Neurol Scand; 1981 Jul; 64(1):29-46. PubMed ID: 7198859
[TBL] [Abstract][Full Text] [Related]
2. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
Fodstad H; Nilsson IM
Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
[TBL] [Abstract][Full Text] [Related]
3. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.
Fodstad H; Pilbrant A; Schannong M; Strömberg S
Acta Neurochir (Wien); 1981; 58(1-2):1-13. PubMed ID: 7282453
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.
Tsementzis SA; Honan WP; Nightingale S; Hitchcock ER; Meyer CH
Acta Neurochir (Wien); 1990; 103(3-4):116-21. PubMed ID: 2205078
[TBL] [Abstract][Full Text] [Related]
5. Antifibrinolytic treatment in subarachnoid haemorrhage: present state.
Fodstad H
Acta Neurochir (Wien); 1982; 63(1-4):233-44. PubMed ID: 7048863
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
Fodstad H
J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
[No Abstract] [Full Text] [Related]
7. On the effects of tranexamic acid and its isobenzedrine ester on plasminogen activation and streptokinase induced fibrinolysis.
Baldacci M; Catalani R; Bartoli C; Del Corso A; Tozzi MG; Mura U
Boll Soc Ital Biol Sper; 1989 Jun; 65(6):521-8. PubMed ID: 2611013
[TBL] [Abstract][Full Text] [Related]
8. Gastric fibrinolysis.
Nilsson IM; Bergentz SE; Hedner U; Kullenberg K
Thromb Diath Haemorrh; 1975 Nov; 34(2):409-18. PubMed ID: 807
[TBL] [Abstract][Full Text] [Related]
9. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid.
Dockeray CJ; Sheppard BL; Daly L; Bonnar J
Eur J Obstet Gynecol Reprod Biol; 1987 Apr; 24(4):309-18. PubMed ID: 2953634
[TBL] [Abstract][Full Text] [Related]
10. Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity.
Alvarez Garijo JA; Vilches JJ; Aznar JA
J Neurosurg; 1980 Apr; 52(4):453-5. PubMed ID: 7373370
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic activity in CSF of patients with SAH in the acute phase measured by a rapid method (correlation with t-AMCA concentration in CSF.
Nishimatsu T; Shibasaki T; Sasaki H; Nukui H
Neurol Med Chir (Tokyo); 1981 Jan; 21(1):85-93. PubMed ID: 6168953
[No Abstract] [Full Text] [Related]
12. Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?
Maurice-Williams RS; Gordon YB; Sykes A
J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):175-81. PubMed ID: 7359154
[TBL] [Abstract][Full Text] [Related]
13. The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysms.
Guidetti B; Spallone A
Surg Neurol; 1981 Apr; 15(4):239-48. PubMed ID: 6166061
[TBL] [Abstract][Full Text] [Related]
14. Morphological changes of the basilar artery, ventricles, and choroid plexus after experimental SAH.
Liszczak TM; Black PM; Tzouras A; Foley L; Zervas NT
J Neurosurg; 1984 Sep; 61(3):486-93. PubMed ID: 6747684
[TBL] [Abstract][Full Text] [Related]
15. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
[TBL] [Abstract][Full Text] [Related]
16. [Fibrinolytic changes in subarachnoid hemorrhage and anti-fibrinolytic therapy--application of an anti-plasmin agent (t-AMCHA)].
Watanabe H; Ishii S; Chigasaki H
Nihon Rinsho; 1978; 36(3):555-62. PubMed ID: 650932
[No Abstract] [Full Text] [Related]
17. Tranexamic acid in the prevention of periventricular haemorrhage.
Hensey OJ; Morgan ME; Cooke RW
Arch Dis Child; 1984 Aug; 59(8):719-21. PubMed ID: 6383225
[TBL] [Abstract][Full Text] [Related]
18. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB.
Zhang Z; Nagata I; Kikuchi H; Xue JH; Sakai N; Sakai H; Yanamoto H
Stroke; 2001 Jul; 32(7):1665-72. PubMed ID: 11441217
[TBL] [Abstract][Full Text] [Related]
19. No hyperfibrinolysis following subarachnoid or intracerebral haemorrhage: a prospective cohort study.
Lauridsen SV; Hvas CL; Sandgaard E; Gyldenholm T; Tønnesen EK; Hvas AM
Blood Coagul Fibrinolysis; 2019 Oct; 30(7):341-349. PubMed ID: 31592776
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits.
Kwan AL; Lin CL; Chang CZ; Winardi D; Yen CP; Wu SC; Lee KS; Kassell NF; Howng SL; Savage P; Jeng AY
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():414S-417S. PubMed ID: 12193135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
